47045-NGA-T-IHVN-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria Nigeria, Tuberculosis, Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Jean-Thomas Nouboussi Fund Portfolio Manager +41 58 791 1700 jean.nouboussi@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Nigeria Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases 5585282.85 Global Fund commitment to NGA-T-IHVNP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 3219286.85 Global Fund disbursement to NGA-T-IHVNP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 50000.00 Global Fund disbursement to NGA-T-IHVNP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 2265996.00 Global Fund disbursement to NGA-T-IHVNP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 50000.00 Global Fund disbursement to NGA-T-IHVNP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria An overview of a grant over its lifetime. General terms and conditions which apply to Global Fund grants. 47045-NGA-T-IHVN-2 The Global Fund to Fight AIDS, Tuberculosis and Malaria Nigeria, Tuberculosis, Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Jean-Thomas Nouboussi Fund Portfolio Manager +41 58 791 1700 jean.nouboussi@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Nigeria Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases 914686.00 Global Fund disbursement to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 282952.00 Global Fund disbursement to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 2099809.23 Global Fund disbursement to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 50000.00 Global Fund disbursement to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 397254.19 Global Fund disbursement to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 1894662.38 Global Fund disbursement to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 459791.39 Global Fund disbursement to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 6381498.24 Global Fund commitment to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria -282343.05 Global Fund commitment to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 4648768.00 Global Fund commitment to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 1541890.00 Global Fund disbursement to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 434216.70 Global Fund disbursement to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 335442.06 Global Fund disbursement to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 50000.00 Global Fund disbursement to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 29779.41 Global Fund disbursement to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 132921.68 Global Fund disbursement to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 2077314.00 Global Fund disbursement to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria -47204.15 Global Fund commitment to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 17904092.34 Global Fund commitment to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 11130453.00 Global Fund disbursement to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 143654.25 Global Fund disbursement to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 12202.92 Global Fund commitment to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 12202.92 Global Fund disbursement to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria -6629985.09 Global Fund commitment to NGA-T-IHVNP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria An overview of a grant over its lifetime. General terms and conditions which apply to Global Fund grants. 47045-NGA-T-IHVN-3 The Global Fund to Fight AIDS, Tuberculosis and Malaria Nigeria, the most populous African nation, ranks 4th among the high tuberculosis (TB) burden countries in the world, according to the 2009 WHO Global TB Report, and first in Africa with an estimated 460,000 new cases annually. TB constitutes a considerable public health problem: in 2007, the national TB Program reported 2,189 TB patient deaths. The TB burden is borne by the entire population, but especially by higher risk populations, such as the urban and rural poor, people living with HIV/AIDS (PLWHA) and those in congregate settings including prison inmates, armed forces personnel, and socially marginalized and displaced persons. There is also a significant socio-economic consequence of TB in Nigeria, as the disease is most prevalent among the most economically productive age range of 15-45 years. In 2010 the WHO estimates, that there were an estimated 11,000 (95% C.I. 1,300-20,000) MDR-TB cases in Nigeria in 2008, based on expected incidence. This corresponds to an estimated MDR-TB rate of 1.8% (95% C.I. 0.0-4.3) among new cases and 7.7% (95% C.I. 0.0-18.1) among retreatment cases. However based on notified pulmonary TB cases in 2009 the best estimate of MDR cases are 1,900 (95% C.I. 600 – 3,900). This Program aims to reduce the TB burden by complementing and accelerating the ongoing activities implemented by government, partners, including USAID, and through the Global Fund Round 5 program (NGA-509-G15-T). In particular, the focus of this Program is to strengthening the MDR TB program implementation. This Program implements the remaining components of the Round 9 TB proposal. That proposal was designed to be “split” into two grants to be implemented by two principal recipients. The DOTS expansion and TB/HIV component was signed in September 2010 with the Association for Reproductive and Family Health (ARFH). The second part of the proposal with the MDR-TB component was not signed due to challenges associated with identifying a principal recipient that met minimum capacity requirements. The CCM nominated one principal recipient in mid-2009 which underwent LFA assessments but which regrettably did not meet minimum requirements. The CCM subsequently launched an open and transparent procedure, based on Global Fund policies, to identify a new principal recipient. Based on this process, the CCM nominated the Institute of Human Virology Nigeria (IHVN) as the Principal Recipient and on 15 December 2010, IHVN was selected as Principal Recipient for this Grant. On 26 March 2010, The Technical Review Panel approved the MDR-TB component of the proposal for a patient cohort of 80 patients (Initial MDR-TB Approval). The CCM with assistance of the WHO TB Team and the Green Light Committee, has also prepared a reprogramming request to the Technical Review Panel of the Global Fund (TRP) to support scale-up and required health system strengthening (HSS) of the MDR-TB program to address previous TRP concerns raised during the TRP clarification process. The TRP has approved the reprogramming request on 23 June 2011 (Scale Up). The Global Fund Board approved a 3 month extension to the signing deadline for this Grant until 20 May 2011 (B22/ER/02). This Grant will also be signed as a SSF grant, fully aligned with the Round 9 TB grant with ARFH (DOTS and TB/HIV). Goals: To contribute to the restoration of public confidence in primary health care services in Nigeria and thereby reverse decline in the utilization of primary health care facilities; To provide Nigerians with universal access to high-quality, patient-centred prevention, diagnosis, and treatment services for TB, TB/HIV, and drug-resistant TB by 2020; To reduce new HIV infections, and improve the quality of life for the infected and affected. Objectives: Objective 1: At least 80% of most at risk population accessing HIV counselling and testing by 2020; Objective 2: PMTCT: At least 90% of all HIV positive pregnant women have access to more efficacious ARV prophylaxis by 2020; Objective 3: ART: At least 70% of eligible adults (women and men) and 70% of children (boys and girls) are receiving ART based on national guidelines by 2017 (Consolidated Target setting meeting, 2014); Objective 4: Achieve an increase in Case Notification Rate of all forms of TB from 57.3% per 100,000 population in 2013 to 287 per 100,000 population in 2020; Objective 5: To increase treatment success rate from 86% in 2013 to 90% by 2020 among drug-susceptible patients; Objective 6: Enrol 100% of diagnosed DR-TB patients on appropriate treatment by 2020. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Jean-Thomas Nouboussi Fund Portfolio Manager +41 58 791 1700 jean.nouboussi@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Nigeria Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases 32253317.00 Global Fund commitment to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 3676306.00 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 336832.90 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 572121.73 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 132369.33 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 50000.00 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 4351947.00 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 300130.57 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 5965903.63 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 55612.21 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 461546.08 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 18841.44 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 7786328.16 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 677788.15 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 1471579.37 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 41362.53 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 67451.48 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 8779064.00 Global Fund commitment to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria -6287196.42 Global Fund commitment to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 3111659.00 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 2307693.00 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 1685219.91 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 7609903.09 Global Fund commitment to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria -1674492.09 Global Fund commitment to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 6739377.00 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 19879.22 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 3877506.53 Global Fund commitment to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria -850646.87 Global Fund commitment to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 2313979.26 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 1563527.27 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 50000.00 Global Fund commitment to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 50000.00 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 16843808.00 Global Fund commitment to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 32182.51 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 2224810.00 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 50000.00 Global Fund commitment to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 4919808.00 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 1073436.30 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 15147220.23 Global Fund commitment to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria -8593571.19 Global Fund commitment to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 1265661.06 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 4461521.74 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 18171.82 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 1604229.10 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria -6688.89 Global Fund commitment to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 6688.89 Funds returned to the Global Fund from NGA-T-IHVNP03. Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria 1126021.22 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 8984.63 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 50000.00 Global Fund disbursement to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria -6662630.66 Global Fund commitment to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 678249.81 Funds returned to the Global Fund from NGA-T-IHVNP03. Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria -678249.81 Global Fund commitment to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 27124.65 Funds returned to the Global Fund from NGA-T-IHVNP03. Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria -27124.65 Global Fund commitment to NGA-T-IHVNP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria An overview of a grant over its lifetime. General terms and conditions which apply to Global Fund grants. Module: MDR-TB. Geographic coverage: Subnational. Aggregation: Cumulative annually. Numerator: 656. Numerator: 285. Numerator: 382. Numerator: 355. Numerator: 569. Numerator: 710. Numerator: 1251. Numerator: 955. Numerator: 872; Denominator: 955; Percentage: 91.3%. Numerator: 1910. Numerator: 1786; Denominator: 1910; Percentage: 93.5%. Numerator: 795. Numerator: 884. Numerator: 1590. Numerator: 1895. Module: MDR-TB. Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 21820; Denominator: 21820; Percentage: 100%. Numerator: 35130; Denominator: 35130; Percentage: 100%. Numerator: 2121. Numerator: 1251. Numerator: 1870. Numerator: 872; Denominator: 1870; Percentage: 46.6%. Numerator: 3740. Module: MDR-TB. Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 1133. Numerator: 2158. Numerator: 775. Numerator: 1326. Numerator: 767. Numerator: 2651. Numerator: 1686. Numerator: 2200. Numerator: 1158; Denominator: 2200; Percentage: 52.6%. Numerator: 4400. Numerator: 2286; Denominator: 4400; Percentage: 52%. Numerator: 2668. Numerator: 1037. Numerator: 5337. Numerator: 2275. Module: MDR-TB. Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 656. Numerator: 649; Denominator: 656; Percentage: 98.93%. Numerator: 649; Denominator: 656; Percentage: 98.93%. Numerator: 7; Denominator: 656; Percentage: 1.07%. Numerator: 7; Denominator: 656; Percentage: 1.07%. Numerator: 218; Denominator: 656; Percentage: 33.23%. Numerator: 218; Denominator: 656; Percentage: 33.23%. Numerator: 438; Denominator: 656; Percentage: 66.77%. Numerator: 438; Denominator: 656; Percentage: 66.77%. Numerator: 0; Denominator: 0. Numerator: 0; Denominator: 0. Numerator: 0; Denominator: 0. Numerator: 0; Denominator: 0. Numerator: 3950. Numerator: 4649. Numerator: 7900. Numerator: 4484. Numerator: 1870. Numerator: 1520; Denominator: 5244; Percentage: 29%. Numerator: 3740. Numerator: 1786; Denominator: 3740; Percentage: 47.8%. Numerator: 1756; Denominator: 1786; Percentage: 98.3%. Numerator: 30; Denominator: 1786; Percentage: 1.7%. Numerator: 630; Denominator: 1786; Percentage: 35.3%. Numerator: 1156; Denominator: 1786; Percentage: 64.7%. Numerator: 22; Denominator: 1786; Percentage: 1.2%. Numerator: 348; Denominator: 1786; Percentage: 19.5%. Numerator: 2668. Numerator: 884. Numerator: 5337. Numerator: 1895. Numerator: 1843. Numerator: 52. Numerator: 662. Numerator: 1233. Numerator: 108. Numerator: 1787. Module: MDR-TB. Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 3; Denominator: 3. Numerator: 6; Denominator: 6. Numerator: 0; Denominator: 6. Numerator: 8; Denominator: 8. Numerator: 0; Denominator: 8. Numerator: 8; Denominator: 8. Numerator: 7; Denominator: 8. Numerator: 7; Denominator: 7. Numerator: 10; Denominator: 10. Module: MDR-TB. Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 18965; Denominator: 52064. Module: MDR-TB. Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 3643; Denominator: 3643; Percentage: 100%. Numerator: 35130; Denominator: 35130; Percentage: 100%. Numerator: 27614; Denominator: 35130; Percentage: 78.6%. Numerator: 36963; Denominator: 24361; Percentage: 151.7%. Numerator: 7900. Numerator: 5244. Numerator: 10488. Numerator: 3341; Denominator: 10488; Percentage: 31.9%. 47045-NGA-T-IHVN-4 The Global Fund to Fight AIDS, Tuberculosis and Malaria Nigeria, Tuberculosis, Institute of Human Virology Nigeria Goals: To ensure universal access to high-quality, patient-centred, prevention, diagnosis and treatment services for TB, TB/HIV and DR-TB by 2020; Responsive and resilient health systems that promote universal access to quality health care services by 2020. Objectives: To increase case notification rate of all forms of TB from 55.1/100,000 population in 2017 to 287 per 100,000 population in 2020; To increase TB treatment success rate from 85% in 2017 to 90% in 2020 among drug susceptible patients; To enrol 100% of diagnosed DR-TB patients on appropriate treatment by 2020; Strengthen health systems for delivery of packages of essential health care services. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Jean-Thomas Nouboussi Fund Portfolio Manager +41 58 791 1700 jean.nouboussi@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Nigeria Tuberculosis Multicomponent, RSSH Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health management information systems and M&E -> Program and data quality RSSH -> RSSH: Health management information systems and M&E -> Routine reporting Tuberculosis -> MDR-TB -> Case detection and diagnosis (MDR-TB) Tuberculosis -> MDR-TB -> Treatment (MDR-TB) Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention) Tuberculosis -> TB care and prevention -> Engaging all care providers (TB care and prevention) Tuberculosis -> TB care and prevention -> Key populations (TB care and prevention) - Others Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention) 15659025.56 40333432.00 27024037.51 Global Fund commitment to NGA-T-IHVNP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 3530765.91 Global Fund disbursement to NGA-T-IHVNP04 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 9561154.48 Global Fund disbursement to NGA-T-IHVNP04 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 164730.69 Global Fund disbursement to NGA-T-IHVNP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 20964.12 Global Fund disbursement to NGA-T-IHVNP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 5246629.19 Global Fund disbursement to NGA-T-IHVNP04 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 8990.40 Global Fund disbursement to NGA-T-IHVNP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 3036818.12 Global Fund disbursement to NGA-T-IHVNP04 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 6985526.81 Global Fund commitment to NGA-T-IHVNP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria -5453984.60 Global Fund commitment to NGA-T-IHVNP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 6985526.81 Global Fund disbursement to NGA-T-IHVNP04 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 23148177.00 Global Fund commitment to NGA-T-IHVNP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 30025.00 Global Fund disbursement to NGA-T-IHVNP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 13152469.00 Global Fund disbursement to NGA-T-IHVNP04 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 21110.60 Global Fund disbursement to NGA-T-IHVNP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 4946659.29 Global Fund disbursement to NGA-T-IHVNP04 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 1798711.23 Global Fund disbursement to NGA-T-IHVNP04 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 7672.50 Global Fund disbursement to NGA-T-IHVNP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 1367.61 Funds returned to the Global Fund from NGA-T-IHVNP04 (Other 3rd Party). Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria -1367.61 Global Fund commitment to NGA-T-IHVNP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 80694.00 Funds returned to the Global Fund from NGA-T-IHVNP04 (Other Local Organizations). Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria -80694.00 Global Fund commitment to NGA-T-IHVNP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria -3191529.38 Global Fund commitment to NGA-T-IHVNP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 15672461.50 Expenditure reported by Institute of Human Virology Nigeria for NGA-T-IHVNP04, Jan 2019 to Dec 2019. Institute of Human Virology Nigeria 30612885.56 Expenditure reported by Institute of Human Virology Nigeria for NGA-T-IHVNP04, Jan 2020 to Dec 2020. Institute of Human Virology Nigeria -79914.30 Expenditure reported by Institute of Human Virology Nigeria for NGA-T-IHVNP04, Jan 2021 to Jun 2021. Institute of Human Virology Nigeria An overview of a grant over its lifetime. General terms and conditions which apply to Global Fund grants. Module: TB care and prevention. Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 11862; Denominator: 104904; Percentage: 11.31%. Numerator: 35498. Numerator: 5863; Denominator: 35498; Percentage: 16.5%. Numerator: 70995. Numerator: 13462; Denominator: 70995; Percentage: 19%. Numerator: 44759. Numerator: 9806. Numerator: 89517. Numerator: 30570. Module: TB care and prevention. Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 11032; Denominator: 12899. 47045-NGA-T-IHVN-5 The Global Fund to Fight AIDS, Tuberculosis and Malaria Nigeria, Tuberculosis, Institute of Human Virology Nigeria Goals: To accelerate efforts at ending TB epidemic in Nigeria by ensuring access to comprehensive and high quality patients' centered and community owned TB (TB. TB/HIV and DR-TB) services for all Nigerians by 2025; To increase the PPM contribution to the National TB case notification from 14% in 2019 to 35% in 2023. Objectives: Coverage: 1a) Increase FBOs engaged in TB services from 81% to 100% 1b) Maintain PFPs engaged in TB services at 15% 1c) Maintain the standalone laboratories engaged in TB services at 19% 1d) Maintain PMVs, CPs & TBAs/Religious houses engaged in TB referral at 38%; Diagnosis: 2a) Notify 213,212 new TB cases 2b) Notify 7,356 DR TB cases 2c) Increase childhood TB cases notified to 15% of all notified TB cases 2d) Clinically screen 100% of OPD attendees at private facilities; Treatment and Prevention: 3a) Place 100% of notified DR TB cases on treatment 3b) Increase the under 5 childhood contacts of TB cases on IPT to 100% 3c) Attain 90% Treatment Success Rate by 2023. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Jean-Thomas Nouboussi Fund Portfolio Manager +41 58 791 1700 jean.nouboussi@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Nigeria Tuberculosis Multicomponent, RSSH Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health management information systems and M&E -> Analysis, evaluations, reviews and transparency RSSH -> RSSH: Health management information systems and M&E -> Program and data quality RSSH -> RSSH: Health management information systems and M&E -> Routine reporting Tuberculosis -> MDR-TB -> Case detection and diagnosis (MDR-TB) Tuberculosis -> MDR-TB -> Treatment (MDR-TB) Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention) Tuberculosis -> TB care and prevention -> Engaging all care providers (TB care and prevention) Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention) 7114152.67 26341199.86 19793216.94 20147956.47 Global Fund commitment to NGA-T-IHVNP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 1622863.00 Global Fund disbursement to NGA-T-IHVNP05 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 393212.50 Global Fund disbursement to NGA-T-IHVNP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 17902.50 Global Fund disbursement to NGA-T-IHVNP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 2812548.00 Global Fund disbursement to NGA-T-IHVNP05 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 2853382.90 Global Fund disbursement to NGA-T-IHVNP05 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 29621678.57 Global Fund commitment to NGA-T-IHVNP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria -12448047.57 Global Fund commitment to NGA-T-IHVNP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 18013631.00 Global Fund disbursement to NGA-T-IHVNP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 12065.00 Global Fund disbursement to NGA-T-IHVNP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 4699801.61 Global Fund disbursement to NGA-T-IHVNP05 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 11193.00 Global Fund disbursement to NGA-T-IHVNP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 14431290.36 Global Fund commitment to NGA-T-IHVNP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria -6884987.96 Global Fund commitment to NGA-T-IHVNP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 1016211.00 Global Fund disbursement to NGA-T-IHVNP05 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 387813.77 Global Fund disbursement to NGA-T-IHVNP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 11193.00 Global Fund disbursement to NGA-T-IHVNP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 1953.24 Funds returned to the Global Fund from NGA-T-IHVNP05 (Other 3rd Party). Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria -1953.24 Global Fund commitment to NGA-T-IHVNP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 779322.90 Global Fund disbursement to NGA-T-IHVNP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 4921.00 Global Fund disbursement to NGA-T-IHVNP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 11305820.06 Global Fund disbursement to NGA-T-IHVNP05 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 46855.00 Funds returned to the Global Fund from NGA-T-IHVNP05 (Other Local Organizations). Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria -46855.00 Global Fund commitment to NGA-T-IHVNP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 1078.19 Funds returned to the Global Fund from NGA-T-IHVNP05 (Other 3rd Party). Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria -1078.19 Global Fund commitment to NGA-T-IHVNP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 24044.77 Global Fund disbursement to NGA-T-IHVNP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 4601151.28 Global Fund commitment to NGA-T-IHVNP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria -901963.86 Global Fund commitment to NGA-T-IHVNP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 10041.85 Funds returned to the Global Fund from NGA-T-IHVNP05 (Other 3rd Party). Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria 12981.00 Global Fund disbursement to NGA-T-IHVNP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria -10041.85 Global Fund commitment to NGA-T-IHVNP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 12981.00 Global Fund disbursement to NGA-T-IHVNP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 2061020.00 Global Fund disbursement to NGA-T-IHVNP05 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 37042.59 Funds returned to the Global Fund from NGA-T-IHVNP05 (Other 3rd Party). Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria -37042.59 Global Fund commitment to NGA-T-IHVNP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 1734732.00 Global Fund disbursement to NGA-T-IHVNP05 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 6659.22 Funds returned to the Global Fund from NGA-T-IHVNP05 (Other 3rd Party). Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria -6659.22 Global Fund commitment to NGA-T-IHVNP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 24854.00 Global Fund commitment to NGA-T-IHVNP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria -779437.28 Global Fund commitment to NGA-T-IHVNP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 24854.00 Global Fund disbursement to NGA-T-IHVNP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria -1760547.00 Global Fund commitment to NGA-T-IHVNP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Institute of Human Virology Nigeria 1760547.00 Funds returned to the Global Fund from NGA-T-IHVNP05 (Other 3rd Party). Institute of Human Virology Nigeria The Global Fund to Fight AIDS, Tuberculosis and Malaria 7151990.07 Expenditure reported by Institute of Human Virology Nigeria for NGA-T-IHVNP05, Jan 2021 to Dec 2021. Institute of Human Virology Nigeria 25296444.15 Expenditure reported by Institute of Human Virology Nigeria for NGA-T-IHVNP05, Jan 2022 to Dec 2022. Institute of Human Virology Nigeria 14748223.84 Expenditure reported by Institute of Human Virology Nigeria for NGA-T-IHVNP05, Jan 2023 to Dec 2023. Institute of Human Virology Nigeria 127698.00 Expenditure reported by Institute of Human Virology Nigeria for NGA-T-IHVNP05, Jan 2024 to Jun 2024. Institute of Human Virology Nigeria An overview of a grant over its lifetime. General terms and conditions which apply to Global Fund grants. Funding Request of funding request FR733-NGA-C. Module: MDR-TB. Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Module: MDR-TB. Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 265. Numerator: 260. Numerator: 260. Numerator: 260. Numerator: 260. Numerator: 260. Numerator: 5. Numerator: 5. Numerator: 5. Numerator: 5. Numerator: 5. Numerator: 104. Numerator: 104. Numerator: 104. Numerator: 104. Numerator: 104. Numerator: 161. Numerator: 161. Numerator: 161. Numerator: 161. Numerator: 161. Numerator: 4. Numerator: 4. Numerator: 4. Numerator: 4. Numerator: 4. Numerator: 261. Numerator: 261. Numerator: 261. Numerator: 261. Numerator: 261. Numerator: 889. Numerator: 128. Numerator: 1778. Numerator: 271. Numerator: 889. Numerator: 143. Numerator: 140; Denominator: 143; Percentage: 97.9%. Numerator: 3; Denominator: 143; Percentage: 2.1%. Numerator: 44; Denominator: 143; Percentage: 30.77%. Numerator: 99; Denominator: 143; Percentage: 69.23%. Numerator: 23; Denominator: 143; Percentage: 16.08%. Numerator: 120; Denominator: 143; Percentage: 83.92%. Numerator: 1208. Numerator: 153. Numerator: 147; Denominator: 153; Percentage: 96.08%. Numerator: 6; Denominator: 153; Percentage: 3.92%. Numerator: 51; Denominator: 153; Percentage: 33.33%. Numerator: 102; Denominator: 153; Percentage: 66.67%. Numerator: 0; Denominator: 153; Percentage: 0%. Numerator: 153; Denominator: 153; Percentage: 100%. Numerator: 2416. Numerator: 341. Numerator: 1208. Numerator: 188. Numerator: 184; Denominator: 188; Percentage: 97.87%. Numerator: 4; Denominator: 188; Percentage: 2.13%. Numerator: 62; Denominator: 188; Percentage: 32.98%. Numerator: 126; Denominator: 188; Percentage: 67.02%. Numerator: 2; Denominator: 188; Percentage: 1.06%. Numerator: 186; Denominator: 188; Percentage: 98.94%. Numerator: 1581. Numerator: 196. Numerator: 189; Denominator: 196; Percentage: 96.43%. Numerator: 7; Denominator: 196; Percentage: 3.57%. Numerator: 70; Denominator: 196; Percentage: 35.71%. Numerator: 126; Denominator: 196; Percentage: 64.29%. Numerator: 15; Denominator: 196; Percentage: 7.65%. Numerator: 181; Denominator: 196; Percentage: 92.35%. Numerator: 3162. Numerator: 377. Numerator: 1581. Numerator: 181. Numerator: 178; Denominator: 181; Percentage: 98.34%. Numerator: 3; Denominator: 181; Percentage: 1.66%. Numerator: 67; Denominator: 181; Percentage: 37.02%. Numerator: 114; Denominator: 181; Percentage: 62.98%. Numerator: 29; Denominator: 181; Percentage: 16.02%. Numerator: 152; Denominator: 181; Percentage: 83.98%. Module: RSSH: Health management information systems and M&E. Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Module: RSSH: Health management information systems and M&E. Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 9522; Denominator: 10773. Numerator: 9522; Denominator: 10773. Numerator: 17597; Denominator: 18949. Numerator: 17597; Denominator: 18949. Numerator: 27902; Denominator: 29374. Numerator: 27902; Denominator: 29374.